The abstract is read at the publisher; the summary is JClub's.
A doubling of prenatal/childhood perfluorooctanoic acid (PFOA) exposure in 259 five-year-old children from the Odense Child Cohort is linked to 38.4% lower tetanus antibody concentrations.
- Why it matters: PFAS are persistent chemicals linked to weaker vaccine-induced immunity, but prior estimates may be biased by imprecise vaccination timing and antibody variability.
- What they did: Using exact vaccination dates from Denmark’s Vaccination Register, the team measured child serum PFAS and tetanus/diphtheria antibodies in samples collected a median of 5.9 weeks after the five-year booster (2015–2018), then fit generalized linear models adjusting for maternal education and time since vaccination.
- The result: Most PFAS–antibody associations showed inverse trends, with PFOS also inverse but weaker (-17.1; 95% CI: -37.6%, 10.2%); higher PFAS corresponded to non-significantly lower odds of protective antibody levels, and prenatal PFAS showed no consistent patterns.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.